Claire Schwab
Dr Ruth Cranston
Dr Sarra Ryan
Ellie Butler
Emily Winterman
et al. | Integrative genomic analysis of childhood acute lymphoblastic leukaemia lacking a genetic biomarker in the UKALL2003 clinical trial | 2023 |
|
Claire Schwab
Daniel Murdy
Ellie Butler
Dr Amir Enshaei
Emily Winterman
et al. | Genetic characterisation of childhood B-other-acute lymphoblastic leukaemia in UK patients by fluorescence in situ hybridisation and Multiplex Ligation-dependent Probe Amplification | 2022 |
|
Dr Aiste McCormick
Dr Peter Donoghue
Michelle Dixon
Dr Rachel O'Donnell
James Murray
et al. | Ovarian Cancers Harbour Defects in Non-Homologous End Joining Resulting in Resistance to Rucaparib | 2017 |
|
Claire Schwab
Sarra Ryan
Dr Lucy Chilton
Alannah Elliott
James Murray
et al. | EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications | 2016 |
|
Dr Asima Mukhopadhyay
Michelle Dixon
Dr Evan Mulligan
James Murray
Professor Nicola Curtin
et al. | Evaluation of different methods to assess homologous recombination status and sensitivity to parp inhibitors in ovarian cancer | 2014 |
|
James Murray
Huw Thomas
Philip Berry
Suzanne Kyle
Dr Miranda Patterson
et al. | Tumour cell retention of rucaparib, sustained PARP inhibition and efficacy of weekly as well as daily schedules | 2014 |
|
Dr Miranda Patterson
James Murray
Professor Nicola Curtin
| Stability of PARP Inhibition by BMN 673 in Human PBMCs (and Leukaemic Cell Cultures) | 2012 |
|
